Page last updated: 2024-10-30

medazepam and Chronic Disease

medazepam has been researched along with Chronic Disease in 2 studies

Medazepam: A benzodiazepine derivative used in the treatment of anxiety. It has sedative, muscle relaxant, and anticonvulsant properties. One of its metabolites is DIAZEPAM and one of its excretion products is OXAZEPAM.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bond, AJ2
James, DC2
Lader, MH2

Trials

2 trials available for medazepam and Chronic Disease

ArticleYear
Sedative effects on physiological and psychological measures in anxious patients.
    Psychological medicine, 1974, Volume: 4, Issue:4

    Topics: Amobarbital; Anti-Anxiety Agents; Anxiety; Auditory Perception; Chlordiazepoxide; Chronic Disease; C

1974
Clinical comparison of anxiolytic drug therapy.
    Psychological medicine, 1974, Volume: 4, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Amobarbital; Anti-Anxiety Agents; Anxiety; Barbiturates; Ca

1974